Cannabis Law Report

AUGUST 10, 2022

According to CAMH’s lead investigator, clinical trials suggest that psilocybin, combined with psychotherapy, can produce “ sustained antidepressant effects” in individuals living with severe depression.

Clinical Trials 52

Clinical Trials Research and Development Therapy Microdosing 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. THC is the psychoactive compound responsible for the “high” associated with marijuana use.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

JUNE 24, 2022

The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws. Full story at.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

SEPTEMBER 12, 2022

All Optimi mushroom products are grown from the Company’s world-leading psilocybin genetic bank and are grown in EU-GMP compliant clean rooms that ensure sterile cultivation and undergo almost 300 different analytical tests post-harvest. To access a complete photo gallery of this historic grow, please click here. Penis Envy.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

JULY 24, 2021

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Fortunately, the U.S. territories.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

MAY 29, 2022

A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada. The psilocybin mushrooms are headed to clinical trials, drug companies and medical facilities. “I’m

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” He later acknowledged that these restrictions have led many “companies [to] go overseas to conduct research with foreign-grown product that is more easily sourced for the purposes of clinical trials.”

DEA 166

DEA Research and Development Clinical Trials Marijuana 166

NORML

JANUARY 18, 2019

Representative Lou Correa (D-CA) this week introduced HR 493: The Sensible Enforcement Of Cannabis Act, which would codify the protections that were outlined in the now-rescinded Cole Memo. House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis.

Legislation 163

Legislation Decriminalization Access Therapy 163

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This unprecedented proposal is contained in the government’s consultation document on giving greater access to medicinal cannabis.

Medicine 40

Medicine Clinical Trials Safety Access 40

SpeedWeed

AUGUST 4, 2021

Medical Cannabis Australia, the company she founded, just obtained its cultivation and manufacture licenses from the Office of Drug Control (ODC) in April of this year. High Times chatted with Bentley to learn more about the personal experience that caused her to be passionate about medical cannabis.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Cannabis Law Report

JUNE 9, 2022

Ukraine’s Health Minister Viktor Liashko announced on June 7 that the government had backed the bill that would legalize medical cannabis amid the war with Russia. The bill aims to improve the quality of medical services for the population that undergoes palliative medicine and encourage medical research on cannabis.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

DECEMBER 14, 2019

Investing in cannabis stocks on the ASX: Risks and benefits for ASX pot stocks. Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. million in the Melbourne cannabis firm in 2018. Writes Investing News.com.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 346

Cultivation DEA Clinical Trials Marijuana 346

Cannabis Law Report

JUNE 11, 2021

We have seen accelerated progress through Mydecine’s fully integrated research and cultivation facilities,” stated Josh Bartch, CEO of Mydecine. Mydecine also operates out of a state-of-the-art mycology lab in Denver, CO to focus on genetic research for scaling commercial cultivation of rare (non-psychedelic) medicinal mushrooms.

Research and Development 59

Research and Development Clinical Trials Therapy Pharmaceutical 59

Cannabis Law Report

MARCH 3, 2022

This was accomplished via the SVG Bureau of Standards creating a Scientific Research License that allows for the cultivation, processing, import/export of psychedelic compounds for medicinal purposes and scientific research. The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52

Cannabis Law Report

OCTOBER 15, 2021

Xebra Brands Ltd. (“ Xebra “), a cannabis company, is pleased to announce that it has received final approval to list its common shares on the Canadian Securities Exchange. Xebra is a cannabis company, with global brands and intellectual property. Xebra’s global brands include beverages, wellness and leisure. federally legalizes).

Seed-To-Sale 52

Seed-To-Sale Cultivation Clinical Trials Cannabinoids 52

Cannabis Law Report

APRIL 10, 2019

Here’s a quick precis care of Cannabis Wire Daily Newswire. In November, UK law changed to allow clinicians to prescribe medical cannabis under limited conditions. Just over 80 prescriptions for medical cannabis (THC and CBD) have been written, according to Hancock. “We Can we unlock the door?”.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

SpeedWeed

JULY 23, 2021

For some, that struggle has inspired them to spread affordable, accessible resources for better mental health. Everybody has an endocannabinoid system regardless of previous hemp or cannabis use. CBD, short for cannabidiol, is one of many compounds found in cannabis plants, including hemp. Take care of yourself.

CBD 52

CBD Sleep Digestion Clinical Trials 52

The Cannigma

DECEMBER 12, 2022

Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. Just as THCA in cannabis flower needs to be decarboxylated into the active compound THC, psilocybin is not active until it undergoes a chemical reaction.

History 119

History Microdosing Research and Development Clinical Trials 119

CannaMD

APRIL 23, 2020

And while there’s currently no known cure for Parkinson’s disease, a marijuana-based medication created by GB Sciences has demonstrated promising results — catching the eye of both the scientific community and medical cannabis patients alike. Advancing Parkinson’s Disease & Cannabis Research. What is GB Sciences?

Clinical Trials 116

Clinical Trials Research and Development Marijuana Treatment 116

The Cannigma

MARCH 12, 2021

Listen & Subscribe: Very few medical cannabis advocates are against the full legalization of the plant for all adults. In this episode of The Cannabis Enigma Podcast, host Michael Schaeffer Omer-Man interviews Dr. Fisher about the various ways medical and adult-use cannabis markets interact. Dr. Ruth Fisher. Music by Desca.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

NOVEMBER 13, 2019

Europe, forecasted to be the world’s biggest legal cannabis market by 2024 will exceed North America, the dominant market today, according to Prohibition Partners. Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

NOVEMBER 24, 2021

Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

FEBRUARY 3, 2022

The approval received this month will enable MediCane to manufacture dry herb and cannabis-based oils, as well as to produce novel formulations for its in-house R&D activity. The number of patients approved for the use of medical cannabis in Israel has increased steadily, reaching over 100,000 in January 2022. Michal Klein Halpern.

Clinical Trials 52

Clinical Trials Research and Development Packaging Oil 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

WeedAdvisor

AUGUST 3, 2019

Brazilian health officials want to pass ground-breaking legislation that would allow for medical marijuana to be grown locally, in addition to permit the sale of cannabis products that are still being studied, reports Marijuana Business Daily. Domestic Cultivation and Products. . Brazil’s case is no different. Opposition. .

Clinical Trials 51

Clinical Trials Cultivation Legislation Cannabis 51

Cannabis Law Report

OCTOBER 3, 2019

Cannabis was high on the regulatory agenda in September, with two significant developments: 1. The Australian Capital Territory ( ACT ) voted to legalise the personal possession and cultivation of cannabis. The ACT Legislative Assembly voted to legalise the personal possession and cultivation of cannabis on 25 September 2019.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

The Joint Blog

FEBRUARY 18, 2020

For the study Israeli investigators examined 59 patients with ADHD who possessed a license from the Ministry of Health to access medical cannabis products. The findings suggest that some ADHD patients may consume cannabis as a “substitute treatment” for more conventional medications, authors concluded.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Cannabis Law Report

FEBRUARY 28, 2020

It took twelve months of research, investigations and interviews (and about five weeks of non-stop writing with some very late nights and a lot of coffee) to produce my book on cannabis law and regulation, which is out now with Bloomsbury Professional. Partisan politics.

Law 59

Law Research and Development Recreational Cannabis 59

Cannabis Law Report

JULY 15, 2022

The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. Secrecy has surrounded a media visit to Queensland’s first licensed cannabis farm, which is nearing completion on the Sunshine Coast.

Medicine 52

Medicine Patients Media Supply Chain 52

SMPL

MAY 26, 2020

A headstrong biochemist, she had been growing marijuana since the age of 14 and had just quit a six-figure job to start her own cannabis testing lab. Cannabis containing significant amounts of CBD was still rare. Cannabis that is high in CBD but extremely low in THC was made legal at the end of 2018.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40